Vol. 3 No. 1 (2020)

Unexpected Treatment in a Severe Covid-19 Patient with Essential Thrombocythemia Who Received Oseltamivir and Hydroxychloroquine A Covid-19 Patient With Thrombocythemia

International Pharmacy Acta, Vol. 3 No. 1 (2020), 14 December 2020 , Page 3e7:1-4
https://doi.org/10.22037/ipa.v3i1.31833

Abstract

Introduction: Novel coronavirus disease (Covid-19) has been recognized as a new human infectious disease caused by a mutated type of coronavirus that might be associated with thrombocytopenia through different mechanisms. Moreover, the presence of underlying disease is a risk of hospitalization and poor prognosis of Covid-19.

Case report: Here, we describe a 77-year-old male Covid-19 patient with essential thrombocythemia. Although gastrointestinal symptoms (GI) were uncommon in the early stages of the pandemic, he presented to a clinic with GI symptoms and general weakness. He didn't have any respiratory involvement and laboratory tests revealed a hemoglobin and platelet reduction (810000/micL to 174000/micL), leukopenia, and elevated D-dimer. He received oseltamivir (75 mg twice daily) and hydroxychloroquine (200 mg twice daily) for five days.

Discussion & Conclusions: Despite his underlying disease and severity of illness including one-month fever, malaise, and a weight loss of 11 kg in ten days, he was cured without any hospitalization.

Keywords:
  • Covid-19
  • Essential thrombocythemia
  • Gastrointestinal symptoms
  • Platelet

How to Cite

Talaie, H., Nazari, M., Hosseini, S. M. ., & Ghanean, H. (2020). Unexpected Treatment in a Severe Covid-19 Patient with Essential Thrombocythemia Who Received Oseltamivir and Hydroxychloroquine: A Covid-19 Patient With Thrombocythemia. International Pharmacy Acta, 3(1), 3e7:1–4. https://doi.org/10.22037/ipa.v3i1.31833

References

1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China 2019. N Engl J Med. 2020;382(8):727-733.
2. Cipriano M, Ruberti E, Giacalone A. Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis. Cureus. 2020;12(3):e7422. doi:10.7759/cureus.7422
3. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020 Apr 12. pii: S0091-6749(20)30495-4. doi: 10.1016/j.jaci.2020.04.006.
4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3.
5. Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, Chen X, Luo M, Liang K, Gao S, Zhang Y, Deng L, Xiong Y. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020 :glaa089. doi: 10.1093/gerona/glaa089.
6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13.
7. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirusdisease 2019 (COVID-19) infections: A meta-analysis. Clinica Chimica Acta. 2020;506:145-148.
8. Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99:1205-1208. doi: 10.1007/s00277-020-04019-0.
9. Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y, Shang Y. Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19. J Thromb Haemost. 2020;18(6):1469-1472.
10. Hydroxychloroquine: Drug information. (2020, May 9). © 2020 UpToDate, Inc. Retrieved from https://www.lib.utdo.ir/contents/hydroxychloroquine-drug information?
11. Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002‐1009. doi:10.1136/gutjnl-2020-320926
12. Sadr S, SeyedAlinaghi S, Ghiasvand F, et al. Isolated severe thrombocytopenia in a patient with COVID-19: A case report. IDCases. 2020;21:e00820. doi:10.1016/j.idcr.2020.e00820
13. Ahmed MZ, Khakwani M, Venkatadasari I, et al. Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review. Br J Haematol. 2020;189 (6): 1057-1058. 10.1111/bjh.16769. doi:10.1111/bjh.16769
  • Abstract Viewed: 474 times
  • PDF Downloaded: 237 times

Download Statastics

Information

Make a Submission

Make a Submission